Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Nicole D. Fleming"'
Autor:
Jeffrey A. How, Amir A. Jazaeri, Pamela T. Soliman, Nicole D. Fleming, Jing Gong, Sarina A. Piha-Paul, Filip Janku, Bettzy Stephen, Aung Naing
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Vaginal and vulvar squamous cell carcinoma (SCC) are rare tumors that can be challenging to treat in the recurrent or metastatic setting. We present a case series of patients with vaginal or vulvar SCC who were treated with single-agent pemb
Externí odkaz:
https://doaj.org/article/aeeef12d0e0e4b5d9337328c2487a6ed
Autor:
Li Zhao, Sara Corvigno, Shaolin Ma, Joseph Celestino, Nicole D. Fleming, Richard A. Hajek, Adrian Lankenau Ahumada, Nicholas B. Jennings, Erika J. Thompson, Hongli Tang, Shannon N. Westin, Amir A. Jazaeri, Jianhua Zhang, P. Andrew Futreal, Anil K. Sood, Sanghoon Lee
Publikováno v:
Cancers, Vol 14, Iss 15, p 3589 (2022)
Patients with high-grade serous ovarian cancer (HGSC) who have no visible residual disease (R0) after primary surgery have the best clinical outcomes, followed by patients who undergo neoadjuvant chemotherapy (NACT) and have a response enabling inter
Externí odkaz:
https://doaj.org/article/b191ed69e2754b75ae6f88dc250611a8
Autor:
Deanna Glassman, Nicholas W. Bateman, Sanghoon Lee, Li Zhao, Jun Yao, Yukun Tan, Cristina Ivan, Kelly M. Rangel, Jianhua Zhang, Kelly A. Conrads, Brian L. Hood, Tamara Abulez, P. Andrew Futreal, Nicole D. Fleming, Vahid Afshar-Kharghan, George L. Maxwell, Thomas P. Conrads, Ken Chen, Anil K. Sood
Publikováno v:
Cancers, Vol 14, Iss 6, p 1496 (2022)
Background: The incidence of venous thromboembolism (VTE) in patients with ovarian cancer is higher than most solid tumors, ranging between 10–30%, and a diagnosis of VTE in this patient population is associated with worse oncologic outcomes. The t
Externí odkaz:
https://doaj.org/article/ab9833b4ce9c41bfbff6cddaea4485b3
Autor:
Sanghoon Lee, Li Zhao, Latasha D. Little, Shannon N. Westin, Amir A. Jazarei, Nicole D. Fleming, Jianhua Zhang, P. Andrew Futreal, Anil K. Sood
Publikováno v:
iScience, Vol 24, Iss 2, Pp 102053- (2021)
Summary: In patients with high-grade serous ovarian cancer (HGSC), it is unclear which genomic features are related to complete gross resection (R0), which is typically associated with better clinical outcomes, or response to neoadjuvant chemotherapy
Externí odkaz:
https://doaj.org/article/2f9666f8a13b42f38edcfd913179c657
Publikováno v:
Cancers, Vol 13, Iss 4, p 626 (2021)
Epithelial ovarian cancer remains a leading cause of death amongst all gynecologic cancers despite advances in surgical and medical therapy. Historically, patients with ovarian cancer underwent primary tumor reductive surgery followed by postoperativ
Externí odkaz:
https://doaj.org/article/d8a80630142245489d4bd33d6f3b46af
Autor:
Yanping Zhong, Jinsong Liu, Xiaoran Li, Shannon N. Westin, Anais Malpica, Barrett C. Lawson, Sanghoon Lee, Bryan M. Fellman, Robert L. Coleman, Anil K. Sood, Nicole D. Fleming
Publikováno v:
Cancers, Vol 13, Iss 4, p 704 (2021)
Background: The impact of chemotherapy response score (CRS) on prognosis has varied among studies. We addressed the prognostic significance of CRS and the prognostic value of previously undescribed histologic features using a cohort of 245 patients.
Externí odkaz:
https://doaj.org/article/cf6c0c0982a845ffadf6506cba5eec57
Autor:
Kaysia Ludford, Won Jin Ho, Jane V. Thomas, Kanwal P.S. Raghav, Mariela Blum Murphy, Nicole D. Fleming, Michael S. Lee, Brandon G. Smaglo, Y. Nancy You, Matthew M. Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind Dasari, Sarah Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen Maru, Scott Kopetz, Michael J. Overman
Publikováno v:
Journal of Clinical Oncology. 41:2181-2190
PURPOSE Pembrolizumab significantly improves clinical outcomes in advanced/metastatic microsatellite instability high (MSI-H)/deficient mismatch repair (dMMR) solid tumors but is not well studied in the neoadjuvant space. METHODS This is a phase II o
Autor:
Katherine I. Foster, Kenna R. M. Shaw, Jeff Jin, Shannon N. Westin, Timothy A. Yap, Deanna M. Glassman, Amir A. Jazaeri, Jose A. Rauh‐Hain, Sanghoon Lee, Bryan M. Fellman, Zhenlin Ju, Yuexin Liu, Nicole D. Fleming, Anil K. Sood
Publikováno v:
Cancer. 129:1672-1680
Autor:
Emily, Hinchcliff, Jennifer, Rumpf, Ravin, Ratan, Nicole D, Fleming, Amir, Jazaeri, Bryan, Fellman, Larissa, Meyer, Pamela, Soliman
Publikováno v:
Gynecologic Oncology. 167:490-495
Uterine leiomyosarcoma (ULMS) is an aggressive malignancy for which hysterectomy is often the primary treatment approach. Due to the rarity of these tumors, the role of oophorectomy in the management of ULMS is not clearly established. This study aim
Autor:
Katelyn F, Handley, Anil K, Sood, Graziela Zibetti Dal, Molin, Shannon N, Westin, Larissa A, Meyer, Bryan, Fellman, Pamela T, Soliman, Robert L, Coleman, Nicole D, Fleming
Publikováno v:
Gynecologic Oncology. 166:50-56
To assess the impact of frailty in patients with ovarian cancer on surgical procedures and outcomes.A retrospective review of patients with stage II-IV ovarian cancer from April 2013 to September 2017 was performed. Patients were triaged by laparosco